Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia—A Retrospective Study

Introduction: Thromboembolic events, including mainly pulmonary embolisms and ischemic strokes, occur in up to one-third of COVID-19 patients. As efficacy of tocilizumab (TCZ) among patients with acute pulmonary embolism (PE) was not previously investigated, this study aimed to provide such data. Ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Chober, Daniel, Aksak-Wąs, Bogusz, Niścigorska-Olsen, Jolanta, Niekrasz, Małgorzata, Parczewski, Miłosz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313102/
https://www.ncbi.nlm.nih.gov/pubmed/35884886
http://dx.doi.org/10.3390/biomedicines10071581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313102/
https://www.ncbi.nlm.nih.gov/pubmed/35884886
http://dx.doi.org/10.3390/biomedicines10071581

Ejemplares similares